129 related articles for article (PubMed ID: 36756924)
21. Novel Structural Insight into Inhibitors of Heme Oxygenase-1 (HO-1) by New Imidazole-Based Compounds: Biochemical and In Vitro Anticancer Activity Evaluation.
Greish KF; Salerno L; Al Zahrani R; Amata E; Modica MN; Romeo G; Marrazzo A; Prezzavento O; Sorrenti V; Rescifina A; Floresta G; Intagliata S; Pittalà V
Molecules; 2018 May; 23(5):. PubMed ID: 29783634
[TBL] [Abstract][Full Text] [Related]
22. A novel experimental heme oxygenase-1-targeted therapy for hormone-refractory prostate cancer.
Alaoui-Jamali MA; Bismar TA; Gupta A; Szarek WA; Su J; Song W; Xu Y; Xu B; Liu G; Vlahakis JZ; Roman G; Jiao J; Schipper HM
Cancer Res; 2009 Oct; 69(20):8017-24. PubMed ID: 19808972
[TBL] [Abstract][Full Text] [Related]
23. Cigarette smoke induces nuclear translocation of heme oxygenase 1 (HO-1) in prostate cancer cells: nuclear HO-1 promotes vascular endothelial growth factor secretion.
Birrane G; Li H; Yang S; Tachado SD; Seng S
Int J Oncol; 2013 Jun; 42(6):1919-28. PubMed ID: 23591596
[TBL] [Abstract][Full Text] [Related]
24. PTEN deletion and heme oxygenase-1 overexpression cooperate in prostate cancer progression and are associated with adverse clinical outcome.
Li Y; Su J; DingZhang X; Zhang J; Yoshimoto M; Liu S; Bijian K; Gupta A; Squire JA; Alaoui Jamali MA; Bismar TA
J Pathol; 2011 May; 224(1):90-100. PubMed ID: 21381033
[TBL] [Abstract][Full Text] [Related]
25. Activity of aminoferrocene-based prodrugs against prostate cancer.
Schikora M; Reznikov A; Chaykovskaya L; Sachinska O; Polyakova L; Mokhir A
Bioorg Med Chem Lett; 2015 Sep; 25(17):3447-50. PubMed ID: 26206503
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of novel imidazole-dioxolane heme oxygenase inhibitors in renal proximal tubule epithelial cells.
Kinobe RT; Ji Y; Vlahakis JZ; Motterlini R; Brien JF; Szarek WA; Nakatsu K
J Pharmacol Exp Ther; 2007 Dec; 323(3):763-70. PubMed ID: 17761847
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, and evaluation of novel mutual prodrugs (hybrid drugs) of all-trans-retinoic acid and histone deacetylase inhibitors with enhanced anticancer activities in breast and prostate cancer cells in vitro.
Gediya LK; Khandelwal A; Patel J; Belosay A; Sabnis G; Mehta J; Purushottamachar P; Njar VC
J Med Chem; 2008 Jul; 51(13):3895-904. PubMed ID: 18543902
[TBL] [Abstract][Full Text] [Related]
28. [Lethal drug interactions of the new antiviral, sorivudine, with anticancer prodrugs of 5-fluorouracil].
Watabe T; Okuda H; Ogura K
Yakugaku Zasshi; 1997 Nov; 117(10-11):910-21. PubMed ID: 9414600
[TBL] [Abstract][Full Text] [Related]
29. Engineering of lipid prodrug-based, hyaluronic acid-decorated nanostructured lipid carriers platform for 5-fluorouracil and cisplatin combination gastric cancer therapy.
Qu CY; Zhou M; Chen YW; Chen MM; Shen F; Xu LM
Int J Nanomedicine; 2015; 10():3911-20. PubMed ID: 26089667
[TBL] [Abstract][Full Text] [Related]
30. Modulating paclitaxel bioavailability for targeting prostate cancer.
Kumar SK; Williams SA; Isaacs JT; Denmeade SR; Khan SR
Bioorg Med Chem; 2007 Jul; 15(14):4973-84. PubMed ID: 17502149
[TBL] [Abstract][Full Text] [Related]
31. How does binding of imidazole-based inhibitors to heme oxygenase-1 influence their conformation? Insights combining crystal structures and molecular modelling.
Carletta A; Tilborg A; Moineaux L; de Ruyck J; Basile L; Salerno L; Romeo G; Wouters J; Guccione S
Acta Crystallogr B Struct Sci Cryst Eng Mater; 2015 Aug; 71(Pt 4):447-54. PubMed ID: 26208625
[TBL] [Abstract][Full Text] [Related]
32. Clofibrate induces heme oxygenase 1 expression through a PPARα-independent mechanism in human cancer cells.
Wang S; Hannafon BN; Zhou J; Ding WQ
Cell Physiol Biochem; 2013; 32(5):1255-64. PubMed ID: 24247298
[TBL] [Abstract][Full Text] [Related]
33. Heme oxygenase levels and metaflammation in benign prostatic hyperplasia patients.
Russo GI; Vanella L; Castelli T; Cimino S; Reale G; Urzì D; Li Volti G; Gacci M; Carini M; Motta F; Caltabiano R; Puzzo L; Sorrenti V; Morgia G
World J Urol; 2016 Aug; 34(8):1183-92. PubMed ID: 26621207
[TBL] [Abstract][Full Text] [Related]
34. A new chalcone derivative, 3-phenyl-1-(2,4,6-tris(methoxymethoxy)phenyl)prop-2-yn-1-one), inhibits phorbol ester-induced metastatic activity of colorectal cancer cells through upregulation of heme oxygenase-1.
Jin H; Kim HS; Seo GS; Lee SH
Eur J Pharmacol; 2018 Dec; 841():1-9. PubMed ID: 30321531
[TBL] [Abstract][Full Text] [Related]
35. A prostate-specific antigen-activated channel-forming toxin as therapy for prostatic disease.
Williams SA; Merchant RF; Garrett-Mayer E; Isaacs JT; Buckley JT; Denmeade SR
J Natl Cancer Inst; 2007 Mar; 99(5):376-85. PubMed ID: 17341729
[TBL] [Abstract][Full Text] [Related]
36. The prodrugs of 5-fluorouracil.
Malet-Martino M; Jolimaitre P; Martino R
Curr Med Chem Anticancer Agents; 2002 Mar; 2(2):267-310. PubMed ID: 12678747
[TBL] [Abstract][Full Text] [Related]
37. Potholing of the hydrophobic heme oxygenase-1 western region for the search of potent and selective imidazole-based inhibitors.
Salerno L; Amata E; Romeo G; Marrazzo A; Prezzavento O; Floresta G; Sorrenti V; Barbagallo I; Rescifina A; Pittalà V
Eur J Med Chem; 2018 Mar; 148():54-62. PubMed ID: 29454190
[TBL] [Abstract][Full Text] [Related]
38. East to West not North-West: Structure-Based Mechanistic Resolution of 8-Hydroxyl Replacement and Resulting Effects on the Activities of Imidazole-Based Heme Oxygenase-1 Inhibitors.
Okunlola FO; Soremekun OS; Olotu FA; Soliman MES
Protein J; 2021 Apr; 40(2):166-174. PubMed ID: 33646477
[TBL] [Abstract][Full Text] [Related]
39. Zinc protoporphyrin suppresses cancer cell viability through a heme oxygenase-1-independent mechanism: the involvement of the Wnt/β-catenin signaling pathway.
Wang S; Avery JE; Hannafon BN; Lind SE; Ding WQ
Biochem Pharmacol; 2013 Jun; 85(11):1611-8. PubMed ID: 23523860
[TBL] [Abstract][Full Text] [Related]
40. Heme oxygenase inhibition by 2-oxy-substituted 1-azolyl-4-phenylbutanes: effect of variation of the azole moiety. X-ray crystal structure of human heme oxygenase-1 in complex with 4-phenyl-1-(1H-1,2,4-triazol-1-yl)-2-butanone.
Roman G; Rahman MN; Vukomanovic D; Jia Z; Nakatsu K; Szarek WA
Chem Biol Drug Des; 2010 Jan; 75(1):68-90. PubMed ID: 19954435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
